Commercial insight into the pharma and biotech sector.
Licensing Deals
Whether you are looking for in-licensing or out-licensing opportunities, need to identify potential product acquisitions arising from M&A activity or appraise growth prospects in underserved or emerging markets, we provide the data and the analytical tools you need so you can quickly find your next deal opportunity.
EvaluatePharma® now offers you access to Partnering Opportunities featuring the latest assets available for Partnering.
Do you have products to out-license? Register to submit your products and reach our global audience of business development and licensing professionals at the world’s top pharma companies.
- Know your deal comparables in an instant
- Track & benchmark existing deals by deal value, upfront payments, royalties & co-promotion
- Quickly find partners in your disease area with successful partnership histories
- See where Big Pharma are spending with deals by therapy areas, phase & technology
- Access unrivalled detail on company Portfolio and Product sourcing with all products classified by strategy including Organic, In-licensed, Company Acquisitions and Joint Ventures
- Search the largest range of deal data including Royalty Rates, Upfront Payment, Development & Sales Milestones
- Drill down with extensive detail of company acquisitions and the products sourced in acquisition
- Run post deal analysis with NPV (Net Present Value) Analyzer and R&D pipeline progression
- Get the latest Licensing news with NewsManager plus expert comment and analysis from
EP Vantage
Register for access to a selection of free analysis and insights